Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

著者: David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink, Joseph J. Eron, Yazdan Yazdanpanah, Daniel Podzamczer, Thomas A. Lutz, Jonathan B. Angel, Gary Richmond, Bonaventura Clotet, Félix Gutiérrez, Louis Sloan, Marty St. Clair, Miranda Murray, Susan L. Ford, Joseph Mrus, Parul Patel, Herta Crauwels, Sandy Griffith, Kenneth Sutton, David Dorey, Kimberly Y. Smith, Peter Williams, William Spreen - The Lancet 2017 被引用: 504